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	 New	N‐substituted‐2‐methyl	quinazolin‐4(3H)‐ones	derivatives	comprising	1,3,4‐thiadiazole,
Schiff	 bases	 and	 2‐azetidinone	moieties	 are	 reported.	The	 structures	of	 the	newly	prepared
compounds	 were	 confirmed	 by	 FT‐IR	 and	 1H	 NMR	 spectra.	 The	 compounds	 were	 also
evaluated	 for	 their	 antimicrobial,	 antioxidant	 and	 study	 of	 inhibition	 on	 some	 enzymes
activities.	 The	 results	 suggest	 that	 the	 compounds	 possess	 broad	 spectrum	 of	 in‐vitro
antimicrobial	 activity.	 Antioxidant	 results	 obtained	 into	 the	 present	 study	 indicate	 that
compound	5	show	moderate	better	scavenging	activity.	Compound 5	demonstrated	inhibitory
effects	 on	GOT,	 GPT,	 GGT	 and	ALP	 activities,	 and	 these	 effects	 increase	with	 increasing	 the
concentration	of	the	compound.	
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1.	Introduction	
	
Quinazolinone	 is	 an	 interesting	 and	 important	 aromatic	
heterocyclic	system.	Substituted	4(3H)	quinazolinones	possess	
a	wide	rang	of	pharmacological	activities	such	as	antimicrobial	
[1,2],	 anticancer	 [3],	 antiviral	 [4],	 anti‐inflammatory	 [5],	 anti‐
tubercular	 [6],	 antitumor	 [7],	 antioxidant	 [8]	 and	 anticon‐
vulsant	[9].	
1,3,4‐Thiadiazole	derivatives	play	role	owing	to	their	wide	
range	of	biological	activity	[10]	and	industrial	applications	[11].	
It	 is	 also	 well	 established	 that	 varion	 derivatives	 of	 1,3,4‐
thiadiazole	exhibit	broad	spectrum	of	pharmacological	proper‐
ties	 such	 as	 anticonvulsant	 [12]	 and	 liver	 enzymes	 inhibition	
[13].	
Furthermore,	 the	 2‐azetidionone	 skeleton,	 otherwise	
known	as	the	β‐lactam	ring,	has	recognized	as	a	useful	building	
block	in	synthesis	of	biologically	important	compounds	[14].	In	
recent	 years,	 significant	 attention	 has	 been	 drawn	 to	 2‐
azetidinone	 derivatives	 due	 to	 their	 diversified	 therapeutic	
activites	 like	antioxidant	and	cholesterol	absorption	 inhibition	
[15].	
	
1.1.	Glutamate	oxaloacetate	transaminase	(GOT)	(EC	
2.6.1.1)	
	
It's	also	called	aspartate	aminotransferase	(AST),	one	of	the	
most	 important	 of	 transaminases	 enzyme,	 and	 catalyzes	 the	
transfer	of	the	amino	group	of	aspartate	to	α‐ketoglutrate.	GOT	
is	 widely	 distributed	 in	 human	 tissues;	 heart,	 liver,	 skeletal	
muscle	 and	 kidney.	 The	 clinical	 usefulness	 of	 the	 enzyme	 is	
largely	 restricted	 to	 the	 diagnosis	 of	 heart	 and	 liver	 diseases.	
Large	amount	of	GOT	may	be	released	into	the	blood.	Very	high	
levels	are	observed	in	acute	liver	disease	while	lesser	elevation	
is	seen	in	chronic	liver	disease	[16‐18].	
	
1.2.	Glutamate	pyruvate	transaminase	(GPT)	(EC	2.6.1.2)	
	
Also	reffered	to	as	alanine	amino	transferase	(ALT),	which	
is	prevalent	 in	mammalian	 tissue	catalyzes	 the	 transfer	of	 the	
amino	 group	 of	 alanine	 to	 α‐ketoglutrate.	 GPT	 found	 in	 a	
highest	concentration	in	liver	in	spite	of	its	active	occurrence	in	
skeletal	muscles,	heart	and	kidney.	The	GPT	activity	 in	 tissues	
is	generally	less	than	GOT.	GPT	level	is	found	to	increase	in	the	
following	 diseases;	 infection	 hepatitis,	 liver	 cirrhosis	 and	
biliary	cirrhosis,	obstructive	jaundice,	liver	cancer	[16,18,19].	
	
1.3.	Gama	glutamate	transferase	(GGT)	(EC	2.3.2.2)	
	
Also	 known	 as	Gama	Glutamate	 Transpeptidase	 (γ‐GT)	 or	
(GGT)	 and	 is	 found	 in	 kidneys	 and	 liver	 and	 catalyzes	 the	
transfer	of	a	gamma‐glutamyl	group	from	glutathione	(GSH)	to	
an	amino	acid.	GGT	levels	are	increased	in	most	 forms	of	 liver	
disease,	 especially	 cholestasis,	 a	 plasma	 membrane‐bound	
enzyme,	 provides	 the	 only	 activity	 capable	 to	 affect	 the	
hydrolysis	 of	 extracellular	 glutathione,	 thus	 favoring	 the	
cellular	utilization	of	its	constituent	amino	acids	[16,20].		
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Scheme	1
	
	
1.4.	Alkaline	phosphatase	(ALP)	(EC	3.1.3.1)	
	
Alkaline	 phosphatase	 is	 present	 in	 high	 concentration	 in	
the	 liver,	 bone	 and	 intestinal	 epithelium.	 These	 tissues	 each	
contain	 specific	 isoenzymes	 of	 ALP.	 Phosphatase	 transfers	 a	
phosphate	 moiety	 from	 one	 group	 to	 another,	 forming	 an	
alcohol	 and	 a	 second	 phosphate	 compound	 at	 high	 pH.	 The	
activity	of	ALP	has	been	elevated	in	the	bone	and	liver	disease	
such	 as	 malignant	 disease	 and	 carcinoma	 with	 osteoblastic	
metastasis	[18,19].	
	
2.	Experimental	
	
2.1.	Materials	and	measurements	
	
All	 reagents	 were	 commercially	 available	 at	 (Aldrich	
Chemical	 Co.)	 and	 were	 used	 without	 further	 purification.	
Melting	 points	 were	 determined	 with	 an	 electrical	 thermal	
melting	 point	 apparatus	 and	 are	 uncorrected.	 Purity	 of	 the	
compounds	 was	 checked	 on	 silica	 coated	 Merck‐TLC	 plates	
using	water,	chloroform	benzene	and	acetone	as	mobile	phase.	
FT‐IR	measurements	were	recorded	on	Shimadzu	model	FT‐IR‐
8400S.	 1H	 NMR	 spectra	 were	 obtained	 with	 a	 Bruker	
spectrophotometer	model	Ultra	Shield	at	300	MHz	in	DMSO‐d6	
solution	with	the	TMS	as	internal	standard.	
	
2.1.1.	Synthesis	of	2‐methyl‐4H‐benzo[d][1,3]	oxazin‐4‐one	
(1)	
	
This	 compound	 has	 been	 synthesized	 by	 following	 the	
procedure	mentioned	in	reference	[21],	by	refluxing	a	mixture	
of	anthranilic	acid	(0.01	mol)	and	10	mL	of	acetic	anhydride	for	
4	 h,	 then	 the	 reaction	 mixture	 was	 cooled	 and	 the	 product	
obtained	was	recrystallized	from	water	(Scheme	1).	Yield:	92%.	
M.p.:	180‐182	°C.	FT‐IR	(KBr,	ν,	cm‐1):	1693	(C=O),	1651	(C=N).	
1H	NMR	(300	MHz,	DMSO‐d6,	δ,	ppm):	8.3‐7.5	(m,	4H,	Ar‐H),	2.4	
(s,	3H,	CH3).	
	
2.1.2.	Synthesis	of	3‐amino‐2‐methyl	quinazolin‐4(3H)‐one	
(2)	
	
A	 mixture	 of	 2‐methyl	 quinazoline‐4(3H)‐one	 (1)	 (0.01	
mol)	and	hydrazine	hydrate	(99%)	(10	mL)	in	absolute	ethanol	
(25	 mL)	 was	 refluxed	 for	 7	 h.	 The	 excess	 of	 solvent	 was	
distilled	off	then	the	product	was	left	to	cool,	filtered	and	then	
recrystallized	from	ethanol	(Scheme	1).	Yield:	78%.	M.p.:	150‐
151	°C.	FT‐IR	(KBr,	ν,	cm‐1):	3370,	3300	(NH2),	1686	(C=O).	1H	
NMR	 (300	MHz,	 DMSO‐d6,	 δ,	 ppm):	 8.4‐6.8	 (4H,	m,	 Ar‐H),	 5.6	
(2H,	s,	NH2),	2.4	(3H,	s,	CH3).	
	
2.1.3.	Synthesis	of	3‐[(5‐amino‐1,3,4‐thiadiazol‐2‐yl)	amino]‐
2‐methyl	quinazolin‐4(3H)‐one	(3)	
	
A	mixture	 of	 3‐amino‐3‐methyl‐quinazoline‐4(3H)‐one	 (2)	
(0.02	 mol)	 and	 2‐amino‐5‐mercapto‐1,3,4‐thiadiazole	 (0.02	
mol)	in	absolute	ethanol	(30	mL)	was	refluxed	for	14	h	till	the	
evolution	 of	 H2S	 finished.	 The	 excess	 solvent	 was	 distilled	 of	
and	 the	 product	 recrystallized	 for	 chloroform	 (Scheme	 1).	
Yield:	60%.	M.p.:	113‐115	°C.	FT‐IR	(KBr,	ν,	cm‐1):	3377,	3279	
(NH2),	1670	(C=O).	1H	NMR	(300	MHz,	DMSO‐d6,	δ,	ppm):	8.61‐
7.56	(m,	4H,	Ar‐H),	6.1	(s,	2H,	NH2),	4.6	(s,	1H,	NH),	2.4	(s,	3H,	
CH3).	
	
2.1.4.	Synthesis	of	(E)‐2‐methyl‐3‐((5‐((3‐nitrobenzylidene)	
amino)‐1,3,4‐thiadiazole‐2‐yl)amino)quinazolin‐4(3H)‐one	
(4)	
	
A	 mixture	 of	 compound	 3	 (0.02	 mol)	 and	 3‐nitro	
benzaldehyde	(0.02	mol))	was	refluxed	in	absolute	ethanol	(25	
mL)	for	7	h.	The	reaction	mixture	was	cooled	and	the	product	
obtained	 recrystallized	 from	 ethanol	 (Scheme	 1).	 Yield:	 75%.	
M.p.:	156‐157	°C.	FT‐IR	(KBr,	ν,	cm‐1):	1690	(C=O),	1617,	(C=N),	
1539,	1324	(NO2).	1H	NMR	(300	MHz,	DMSO‐d6,	δ,	ppm):	8.5	(s,	
1H,	N=CH),	8.27‐7.63	(m,	8H,	Ar‐H),	4.7	(s,	1H,	NH),	2.3	(s,	3H,	
CH3).	
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2.1.5.	Synthesis	of	3‐((5‐(3‐chloro‐2‐(3‐nitrobenzyl)‐4‐oxo	
azetidin‐1‐yl)‐1,3,4‐thiadiazol‐2‐yl)amino)‐2‐methyl	
quinazolin‐4(3H)‐one	(5)	
	
To	 a	 stirred	 solution	 of	 compound	 M4	 (0.01mol)	 and	
triethyl	 amine	 (0.02	mol)	 in	 dry	 dioxin	 (15	mL),	 chloroacetyl	
chloride	 (0.02	 mol)	 was	 added	 dropwise	 at	 (0‐5	 °C),	 the	
reaction	mixture	was	then	stirred	for	6	h,	then	poured	into	ice‐
water.	 The	 solid	was	 filtered	 and	 recrystallized	 from	benzene	
(Scheme	1).	Yield:	66%.	M.p.:	175‐177	°C.	FT‐IR	(KBr,	ν,	cm‐1):	
1755	(C=O,	β‐Lactom),	1653	(C=O).	1H	NMR	(300	MHz,	DMSO‐
d6,	δ,	ppm):	7.37‐6.81	(m,	8H,	Ar‐H),	4.6	(s,	1H,	NH),	4.9	(d,	1H,	
N‐CH),	5.0	(d,	1H,	CH‐Cl),	2.4	(s,	3H,	CH3).	
	
2.2.	Biological	activities	
	
2.2.1.	Antimicrobial	activity	
	
The	 in	 vitro	 antimictrobial	 screening	 effects	 of	 the	
synthesized	 compounds	 evaluated	 against	 two	 Gram	 positive	
Staphylococcus	 aureus	 and	 Streptococcus	 pyogenes	 and	 two	
gram	 negative	 bacteria	 Escherichia	 coli	 and	 Pseudomonass	
aeruginosa	and	two	fungal	strains	namely	Candida	albicans	and	
Aspergillus	niger	using	well	diffusion	method	[22].	
DMSO	was	run	as	a	control	and	the	test	was	performed	at	
10	mg/mL	concentration	using	DMSO	as	solvent.	The	bacteria	
and	 fungi	were	sub‐cultured	 in	agar	and	potato	dextrose	agar	
medium	and	were	incubated	for	24	h	for	bacteria	and	48	h	for	
fungi	at	37	°C.	
 
2.2.2.	Antioxidant	activity	
	
The	free	radical	scavenging	activity	of	compound	5	towards	
the	 radical	 (DPPH)	 1,1‐diphenyl‐2‐picryl	 hydrazyl	 was	
measured	 as	 described	 by	 reference	 [23].	 The	 2‐azetidinone	
stock	solution	(1	mg/mL)	was	diluted	to	final	concentration	of	
20‐100	 µg/mL.	 Methanolic	 DPPH	 solution	 (1	 mL,	 0.3	 mmol)	
was	 added	 to	 sample	 solution	 in	 DMSO	 (3	 mL)	 at	 different	
concentration.	
The	mixture	was	shaken	vigorously	and	allowed	to	stand	at	
room	 temperature	 for	 30	 min.	 the	 absorbance	 was	 then	
measured	 at	517	nm	 (As),	 using	 “Shimadzu175	 spectrophoto‐
meter”.	 The	 methanol	 solution	 of	 DPPH	 was	 used	 as	 control	
sample	 Ac.	 The	 ability	 of	 scavenge	 the	 DPPH	 radical	 was	
calculated	using	the	following	formula:	
	
%	Radical	scavenging	activity	=	100	×	(Ac‐As)/Ac	 (1)	
	
Methanol	was	used	as	the	solvent	and	ascorbic	acid	as	the	
standard.	
	
2.2.3.	Effect	of	compound	5	on	some	enzymes	activities	
	
2.2.3.1.	Effect	of	compound	5	on	GOT	and	GPT	activities	
	
Colorimetric	 determination	 of	 GOT	 or	 GPT	 activity	 accor‐
ding	to	the	following	reactions:	
	
	 (2)	
	
	 (3)	
	
The	 pyruvate	 or	 oxaloacetat	 formed	 was	 measured	 in	 its	
derivated	 form	 2,4‐dinitrophenylhydraone,	 which	 was	 absor‐
bed	at	wave	length	505	nm	[16,24]	.	
	
2.2.3.2.	Effect	of	compound	5	on	GGT	activity	
	
Kinetic	 colorimetric	method	 for	 the	 determination	 of	 GGT	
activity	 was	 assayed	 by	 Persijn	 and	 Van	 Der	 Slik	 [25].	 The	
principle	of	the	method	was	the	measurement	of	the	5‐amino‐
2‐nitro‐benzoate	 form	 from	 reaction,	 which	 was	 absorbed	 at	
wave	length	405	nm	[16].	
	
L‐‐gluamyl‐3‐carboxy‐4‐nitroanlide +Glycylglycine GGT
L‐‐glutamy‐glycylglycine+ 5‐Amino‐2‐nitrobenzoat 	(4)	
	
2.2.3.3.	Effect	of	compound	5	on	ALP	activity	
	
Colorimetric	determination	of	ALP	activity	according	to	the	
following	reaction.	
	
	 	(5)		
	
The	 phenyl	 phosphate	 was	 hydrolyzed	 to	 phenol,	 which	
was	 measured	 in	 the	 presence	 of	 amino‐4‐antipyrine	 and	
potassium	ferricyanide,	which	was	yellow	 in	alkaline	solution,	
and	absorbed	at	wave	 length	520	nm	[26].	The	enzymes	GOT,	
GPT,	 GGT	 and	ALP	 activities	were	measured	 in	human	 serum	
using	above	methods	with	added	100	µL	of	DMSO	to	calculate	
the	 activities	 of	 these	 enzymes	 without	 inhibitors.	 A	 stock	
solution	 (0.1	 M)	 of	 compound	 5	 were	 prepared	 and	 the	
following	 concentration	 of	 1×10‐2,	 1×10‐3,	 1×10‐4,	 1×10‐5,	 and	
1×10‐6	 M	 were	 prepared,	 diluting	 with	 dimethyl	 sulfoxide	
(DMSO).	The	enzymes	GOT,	GPT,	GGT	and	ALP	activities	were	
measured	 in	 human	 serum	 using	 the	 same	methods	 of	 these	
enzymes	 with	 replaces	 100	 µL	 of	 DMSO	 with	 100	 µL	 of	
compound	5	[16].	
The	 inhibition	 percentages	 were	 calculated	 by	 comparing	
the	 activities	 with	 and	without	 the	 compound	 and	 under	 the	
same	conditions,	according	to	the	equation	[16].	
		
		 	 	 	 	 	 (6)	
	
A	constant	concentrations	of	compound	5	1×10‐2	and	1×10‐
4	M	were	used	with	different	substrate	concentrations	of	40,	80,	
120,	160	and	200	mmol/L	for	GOT,	GPT	0.4,	0.8,	1.2,	1.6	and	2.0	
mmol/L	for	γ‐GT	and	1,	2,	3,	4	and	5	mmol/L	for	ALP	to	study	
the	 types	of	 inhibition.	Buffers	were	used	 to	prepare	different	
substrates	 concentrations	 of	 these	 enzymes,	 GOT,	 GPT	
(phosphate	buffer	pH	=	7.4,	100	mmol/L),	γ‐GT	(TRIS	buffer	pH	
=	8.25,	100	mmol/L)	and	ALP	(carbonate	buffer	pH	=	10,	100	
mmol/L).	
Competitive,	noncompetitive	 and	uncompetitive	 inhibition	
can	 be	 easily	 distinguished	with	 the	 use	 of	 double	 reciprocal	
plot	 of	 the	 Lineweaver‐Burk	 plot.	 Two	 sets	 of	 rate	 deter‐
mination	 in	 which	 enzyme	 concentration	 was	 held	 constant,	
were	 carried	 out.	 In	 the	 first	 experiment	 the	 velocity	 of	
uninhibited	 enzyme	 was	 established,	 in	 the	 second	 experi‐
mental	constant	amount	of	inhibitor	is	included	in	each	enzyme	
assay.	 Varieties	 of	 substances	 have	 the	 ability	 to	 reduce	 or	
eliminate	the	catalytic	activity	of	specific	enzyme.	
When	the	enzymes	activity	is	determined	with	and	without	
compound	5,	 it	 can	be	 calculate	 the	 [ki,	 Apparent	vmax	 (vmapp),	
Apparent	 km	 (kmapp),	 type	 of	 inhibition]	 by	 using	 Lineweaver‐
Burk	equation	and	plotting	1/v	against	1/[s]	[19].		
	
3.	Results	and	discussion	
	
3.1.	Synthesis	
	
The	 new	 quinazolinone	 derivatives	 were	 prepared	
following	the	reaction	sequences	depicted	in	Scheme	1.		
The	 3‐amino‐2‐methylquinazolin‐4(3H)‐one	 (2)	 was	 pre‐
pared	 by	 refluxing	 of	 compound	1	 with	 hydrazine	 hydrate	 in	
absolute	ethanol	for	7	h.		
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Table	1.	Antimicrobial	evaluation	of	compounds	3‐5.	
Compound	 Antibacterial	Activity	 Antifungal	Activity	
Zone	of	inhibition	in	(mm)	
Gram	positive	 Gram	negative	 Fungi	
S.	aureus	 S.	pyogenes	 P.	aeragines E.	coli C.	albicans	 A.	niger
3	 112	 100	 120 118 70 65	
4	 130	 110	 130 140 75 78	
5	 155	 140	 150 155 100 80	
Ampicillin	 100	 100	 100 100 ‐ ‐	
Fluconazole	 ‐	 ‐	 ‐ ‐ 100 100
	
	
	
	
Figure	1.	%	Scavenging	activity	of	the	compound	5 using DPPH.
	
	
IR	spectrum	of	compound	2	showed	the	appearance	of	new	
characteristic	bands	at	3370,	3300,	1686	and	1629	cm‐1,	which	
belonged	 for	 NH2,	 C=O,	 C=N,	 respectively.	 While	 the	 1H	 NMR	
showed	 singlet	 signal	 at	 2.4	ppm	due	 to	methyl	 proton	 and	 a	
singlet	 at	 6.1	 ppm	 related	 to	 NH2,	 while	 a	multiplet	 signal	 at	
7.61‐8.05	ppm	due	to	four	aromatic	protons.	
Reaction	 of	 compound	 2	 with	 2‐amino‐5‐mercapto‐1,3,4‐
thiadiazole	 afforded	 compound	 3.	 The	 reaction	 was	 followed	
using	 lead	 acetate	paper	 till	 the	 end	of	 liberation	of	H2S.	 This	
reaction	 occurs	 via	 nucleophilic	 replacement	 of	 SH	 by	 amino	
group	 of	 compound	 2.	 The	 IR	 spectrum	 showed	 absorption	
bands	due	to	NH2	at	3336	and	3254	cm‐1	and	NH	band	at	3134	
cm‐1	for	NH.	
Condensation	of	compound	3	with	3‐nitrobenzaldehyde	in	
absolute	 ethanol	 gave	 Schiff	 base	 (4).	 The	 formation	 of	 Schiff	
base	was	 indicated	 by	 the	 presence	 in	 their	 IR	 spectra	 of	 the	
azomethine	 (CH=N)	 stretching	 band	 at	 1617	 cm‐1,	 combined	
with	the	disappearance	of	NH2	stretching	band.	
On	the	other	hand,	the	cyclo	addition	of	Schiff	base	(4)	with	
chloroacetyl	 chloride	 in	 triethylamine	 and	 dioxane	 yielded	
azetidinyl	 derivative	 compound	 5.	 The	 IR	 spectrum	 of	
compound	5	 showed	 the	disappearance	band	of	 (CH=N)	 from	
azomethine	 at	 1617	 cm‐1,	 combined	 with	 the	 appearance	 of	
absorption	band	at	1755	cm‐1	 (C=O)	 for	β‐lactam	ring.	The	 1H	
NMR	spectrum	of	compound	5	showed	singlet	signal	at	4.6	ppm	
due	 to	 NH	 and	 two	 doublets	 one	 at	 4.9	 ppm	 relate	 to	 N‐CH	
another	 at	 5.0	 ppm	 due	 to	 CH‐Cl,	 while	 amultiplet	 signal	 at	
7.37‐6.81	ppm	due	to	aromatic	protons.	
	
3.2.	Biological	activities	
	
3.2.1.	Antimicrobial	activity	
	
Standard	 antibacterial	 drug	 (Ampicillin)	 and	 antifungal	
drug	(Fluconazole)	were	used	for	comparison.	The	experiments	
were	performed	in	triplicate	in	order	to	minimize	errors.	
Zone	 of	 inhibition	 produced	 by	 each	 compound	 was	
measured	 in	mm	 and	 the	 results	 of	 antimicrobial	 studies	 are	
given	 in	 Table	 1.	 Compound	 3,	 4,	 and	 5	 are	 potential	
antimicrobial.	It	seems	that	the	compound	5	is	very	significant	
for	activity	against	both	bacterial	and	fungal	species	due	to	the	
presence	of	β‐lactam	ring.	
	
3.2.2.	Antioxidant	activity	
	
Hydrogen	peroxide	is	generated	in	vivo	by	several	oxidase	
enzymes	 and	 which	 product	 hydroxyl	 radical	 causes	 severe	
damage	 to	 biological	 systems.	 The	 antioxidant	 potential	 of	
compound	5	was	determined	on	the	basis	of	 its	scavenging	of	
the	 stable	 (DPPH)	 free	 radical.	 Figure	 1	 showed	 that	 the	
compound	 5	 exhibit	 excellent	 antioxidant	 properties,	 the	
potential	 is	 comparable	 with	 antioxidant	 activity	 of	 ascorbic	
acid	activity.	This	may	be	due	to	the	presence	of	‐NH	group.	
	
3.2.3.	Effect	of	compound	5	on	some	enzymes	activities	
	
The	 biochemical	 tests	 revealed	 that	 compound	 5	 caused	
inhibitory	effects	on	all	enzymes	activity.	Figure	2	showed	that	
the	 different	 concentration	 of	 compound	 5	 caused	 inhibitory	
effects	 on	 GOT,	 GPT,	 GGT	 and	 ALP	 enzyme,	 the	 value	 of	 the	
GOT,	GPT,	GGT	and	ALP	enzymes	activities	without	compound	
5	were	18,	16,	6.545	and	30	U/L,	respectively.	The	relationship	
between	compound	5	concentration	versus	and	the	activities	of	
enzyme	as	shown	 in	Figure	3,	 these	results	observed	 that	any	
increase	 in	 compound	 concentrations	 caused	 increase	 in	
percentage	of	 inhibition	of	 enzymes.	The	 greater	 inhibition	of	
compound	5	was	demonstrated	at	concentration,	1×10‐2	M	[16].	
Figure	4	showed	that	 the	 inhibitory	effect	by	compound	5	
was	 higher	 inhibitory	 on	 the	 ALP	 enzyme	 (%33.3)	 and	 the	
lower	inhibitory	effect	was	on	the	GOT	enzyme	(%25.5).	
By	 using	 double	 reciprocal	 plot	 of	 the	 Lineweaver‐Burk	
plot	 can	 be	 easily	 distinguished	 type	 of	 inhibition	 of	 enzyme	
activity,	when	was	established	the	velocity	of	enzyme	with	and	
without	inhibitor.	
Table	 2	 and	 Figure	 5	 showed	 that	 the	 type	 of	 enzyme	
inhibitin	using	Lineweaver‐Burk	plot	for	compound	5	on	serum	
GOT,	GPT,	GGT	and	ALP	activities.	A	liquate	10‐2	and	10‐4	M	of	
compound	5	were	 non‐competitive	 inhibition	 for	 all	 enzymes	
activities.	 Non‐competitive	 inhibition	 changed	 the	 Vmax	 of	 the	
enzyme	but	not	the	Km.	Km	with	10‐2	and	10‐4	M	of	compound	5	
on	 GOT,	 GPT,	 GGT	 and	 ALP	 enzymes	 were	 200,	 500,	 1,	 5	 M,	
respectively.		
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Figure	2.	The	relationship	between	concentration	of	compound	5	and	GOT,	GPT,	GGT	and	ALP	enzymes	activities.	
	
	
	
	
	
	
	
	
	
Figure	3.	The	percentages	of	inhibition	of	GOT,	GPT,	GGT	and	ALP	enzymes	and	compound	5 concentration.	
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Table	2.	The	kinetic	properties	of	GOT,	GPT,	GGT	and	ALP	with	compound	5. 
Enzymes	 Concentration	of	compound	5	 kmap,	km	(M)	 vmap	U/L	 ki	(M)	 Type	of	inhibition	
GOT	 10‐2	 200 20 25x10‐4 Non‐competitive	
10‐4	 200 11.12 125	x10‐7 	
GPT	 10‐2	 500	 10	 25x10‐4	 Non‐competitive	
10‐4	 500 20 66x10‐6
GGT	 10‐2	 1	 0.4	 25x10‐4	 Non‐competitive	
10‐4	 1 0.72 55x10‐6
ALP	 10‐2	 5.00 20 66x10‐4 Non‐competitive	
10‐4	 5.00 33.3 2x10‐4
	
	
	
	
Figure	4.	%	Inhibition	of	GOT,	GPT,	GGT	and	ALP	enzymes	activities	with	1×10‐2 M	of	compound	5.	
	
	
	
	
	
	
	
	
Figure	5.	Lineweaver‐Burk	plots	for	compound	5 effects	on	GOT,	GPT,	GGT	and	ALP.
	
	
Vmax	and	Vmapp	with	10‐2	and	10‐4	M	of	compound	5	on	GOT,	
GPT,	GGT	and	ALP	enzymes	were	(100,	20,	11.12),	(50,	10,	20),	
(2,	0.4,	0.72),	(50,	20,	33.3),	respectively.	By	using	Lineweaver‐
Burk	 equation	 was	 calculated	 the	 Ki	 values	 of	 enzymes	 for	
compound	which	was	studied	in	different	concentration.	The	Ki	
of	compound	5	 in	10‐2	and	10‐4	M	on	GOT,	GPT,	GGT	and	ALP	
enzymes	 were	 (25×10‐4,	 125×10‐7),	 (25×10‐4,	 66×10‐6),				
(25×10‐4,	55×10‐6),	(66×10‐4,	2×10‐4)	M,	respectively.	
The	enzymes	play	important	role	in	amino	acid	metabolism	
and	in	the	urea	and	tricarboxylic	acid	cycles.	We	suggested	that	
compound	 5	 molecule	 has	 (N‐,	 O=,	 Cl,	 S	 and	 NO2)	 groups	 by	
which,	 molecular	 of	 compound	 5	 interaction	 between	 the	
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groups	with	 GOT,	 GPT,	 GGT	 and	 ALP	 enzymes,	 it	 inhibite	 the	
active	 sides	 enzymes	 by	 decreasing	 affinity	 of	 active	 sides	 of	
enzymes	to	react	with	the	substrates.	The	results	of	our	study	
are	 in	 agreement	 with	 before	 studies	 of	 same	 enzyme	 [17‐
19,23].	
The	tripeptide	glutathione	(GSH)	is	used	by	cells	to	detoxify	
hydroperoxides,	 produced	 during	 oxidative	 stress,	 and	 is	
consumed	 in	the	process.	Previous	studies	have	 indicated	that	
cells	can	be	protected	against	oxidative	stress	by	extracellular	
GSH	 through	 its	 degradation	 catalyzed	 by	 the	 exoenzyme	
gamma‐glutamyl	 transpeptidase	 (GGT)	 and	 its	 de	 novo	
synthesis	within	the	cytosol	 [24].	Because	of	this,	 induction	of	
GSH	 depletion	 has	 been	 proposed	 as	 a	 good	 strategy	 for	
sensitizing	 tumor	 cells	 to	 anti‐tumor	 agents	 [25].	 We	
hypothesized	 that	 (GGT)	 would	 be	 increased	 as	 part	 of	 the	
adaptation	of	cells	to	oxidative	stress.	
	
4.	Conclusions	
	
New	 derivatives	 of	 2‐methyl	 quinazolin‐4(3H)‐one	 were	
synthesized	and	characterized	using	spectroscopic	techniques.	
We	 studied	 the	 antimicrobial	 activities	 of	 these	 derivitives	
against	 some	 gram	 positive	 and	 negative	 species	 as	 well	 as	
fungal	species.	It	seems	that	the	compound	5	is	very	significant	
for	 activity	 against	 both	 bacterial	 and	 fungal	 species	 and	 it	 is	
excellent	 antioxidant	 properties	 when	 comparable	 with	
antioxidant	 activityof	 ascorbic	 acid.	 Compound	 5	 is	 weakly	
inhibition	 on	 GOT,	 GPT,	 GGT	 and	 ALP	 enzymes	 activities.	 So,	
compound	 5	 can	 be	 used	 as	 easily	 accessible	 source	 of	
antioxidant	and	in	pharmaceutical	industry.	
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